Credit Agricole’s ADMA Biologics ADMA Stock Holding History

Credit Agricole’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.11M	Hold	55,719	–	–	﹤0.01%	883
2024 Q4	$956K	Buy	55,719 +20,370	+58%	+$383K	﹤0.01%	941
2024 Q3	$707K	Buy	+35,349	New	+$550K	﹤0.01%	879

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Credit Agricole's ADMA Position: Q1 2025 in Review

Credit Agricole held its ADMA Biologics (ADMA) position steady in Q1 2025 at 55,719 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #883.

Credit Agricole first reported a position in ADMA in Q3 2024 and has held it in 3 quarters since. 347 funds tracked by Wall St. Rank hold ADMA as of Q1 2025.

Credit Agricole held 55,719 shares of ADMA Biologics worth $1.11M as of Q1 2025.
Credit Agricole left its ADMA Biologics share count unchanged in Q1 2025.
ADMA Biologics made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #883 holding.
Credit Agricole first reported a position in ADMA Biologics in Q3 2024 and has held it in 3 quarters since.
347 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.